The vaccine, Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, is the first adjuvanted influenza vaccine approved by FDA and is for use in people 18 years of age and older who...

A H5N1 vaccine is an influenza vaccine intended to provide immunization to influenza A virus subtype H5N1. Vaccination of poultry against the avian H5N1 influenza epizootic is …

For active immunization of persons 18 through 64 years of age at increased risk of exposure to the H5N1 influenza virus subtype contained in the vaccine.

Apr 24, 2024 · On the heels of a multi-state outbreak of highly pathogenic avian influenza A (H5N1) in dairy cows, experts told MedPage Today that a trio of H5N1 vaccines for humans …

Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted is approved for use in persons (6 months and older) at increased risk of exposure to the influenza A virus H5N1 subtype …

Is a vaccine available to prevent human infection with H5N1 viruses? As part of their influenza pandemic preparedness work, some countries have developed and licensed vaccines that …

Dec 31, 2024 · The CDC still designates the risk of HPAI A(H5N1) to most Americans as low. We do have candidate vaccines and antivirals available to try to mitigate severe influenza in the …

Jul 2, 2024 · Currently, risk to human health from H5N1 is low, and vaccination is not recommended for any segment of the population. What are the safety risks associated with …

Jan 8, 2025 · Description for Arepanrix. AREPANRIX (Influenza A [H5N1] Virus Monovalent Vaccine, Adjuvanted) is a sterile injectable emulsion for intramuscular use.The vaccine is …

Mar 28, 2023 · Influenza Virus Vaccine, H5N1 is used to help prevent disease in people who are at risk of coming into contact with infected birds or other sources of the virus. Influenza Virus …